Johnson & Johnson Stock
Forget the Bears, Own JNJ Stock for Dividends Commanding a market capitalization of well over $300.0 billion, Johnson & Johnson (NYSE:JNJ) stock is not known for making big moves. But since the beginning of 2018, shares of the company have.
Johnson & Johnson Is Still a Top Dividend Stock Over the years, blue-chip stocks have delivered a tremendous amount of value to income investors. But because many large-cap companies have also become household names, their share prices have gotten expensive..
JNJ Stock: A Boring Business That Delivered 600% Return in the Last 20 Years If the idea of buying a stock and holding it forever sounds good to you, then you should take a serious look at Johnson & Johnson.
1 Top Dividend Stock for 2017 and Beyond When it comes to helping income investors achieve their goals, few have done a better job than Johnson & Johnson (NYSE:JNJ) stock. The key here is dividend growth. As consumers, we have.
JNJ Stock Delivering Enormous Returns The thing with dividend stocks like Johnson & Johnson (NYSE: JNJ) is that they don’t really work that well in a conversation at a cocktail party. When asked about your stock market investments, people will.
JNJ Stock Keeps Rewarding Dividend Investors There seems to be an overwhelming amount of uncertainty in the markets these days, which is why I believe it’s time to revisit Johnson & Johnson (NYSE:JNJ) stock. Most investors buying Johnson & Johnson.
JNJ Stock: A Top Dividend Stock for Income Investors In a world where a decent return on investment is hard to come by, Johnson & Johnson (NYSE:JNJ) stock presents an example of a unique investment opportunity for investors seeking a.
Johnson & Johnson Stock: A Blue-Chip Industry Giant There are few stocks that can match Johnson & Johnson (NYSE: JNJ); it is quite simply the gold standard for dividend stocks. It offers virtually everything an income investor would want. Not.
JNJ Stock: 54 Consecutive Years of Dividend Hikes If you are wondering why Johnson & Johnson (NYSE:JNJ) stock deserves a spot on every income investor’s watchlist, here’s a number: 54. That’s how many years the health care giant has been.